Author

Yuzo Shimazu

Fukushima Medical UniversityORCID 0000-0002-8402-2789Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Akifumi Kamiyama· 1 shared Akira SugiyamaiD· 1 shared Aya NakayamaiD· 1 shared Chika YamamotoiD· 1 shared Fumiya OmataiD· 1 shared Hiroshi MoriokaiD· 1 shared Hyeongki ParkiD· 1 shared Katsuhiro KatoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Akifumi Kamiyama

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection

Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, Yoshitaka Sato, Kwang Su Kim, Kosaku Kitagawa, Yurie Kobashi, Yuta Tani, Yuzo Shimazu, Tianchen Zhao, Yoshitaka Nishikawa, Fumiya Omata, Moe Kawashima, Toshiki Abe, Yoshika Saito, , Masaharu Tsubokura

The paper analyzes longitudinal antibody titers post-vaccination to identify individuals at risk for breakthrough infections and identifies three population groups with distinct immune response patterns.

bioRxiv · Mar 1, 2025 · PreprintImmunology